HAWKINS INC. 10-Q Summary: Quarter Ended June 30, 2010
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2010 (Fiscal Q1 2011). Hawkins, Inc. is a distributor of bulk and specialty chemicals operating primarily within the United States. The company operates through two reportable segments: Industrial and Water Treatment. The Pharmaceutical segment was divested in fiscal 2010 and is reported as discontinued operations.
Key Financial Metrics
| Metric | Q1 2011 (Jun 30, 2010) | Q1 2010 (Jun 30, 2009) |
|---|---|---|
| Sales | $74.7 million | $73.6 million |
| Gross Profit | $18.4 million (24.7% margin) | $15.9 million (21.5% margin) |
| Operating Income | $11.8 million (15.8% margin) | $9.5 million (12.9% margin) |
| Net Income | $7.3 million | $6.1 million |
| Diluted EPS | $0.71 | $0.59 |
| Cash from Operations | $4.6 million | $11.7 million |
| Cash & Investments | $52.1 million | $53.7 million (prior period end) |
| Debt | None reported | None reported |
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 1.5% year-over-year, driven by a 4.2% increase in the Water Treatment segment, while the Industrial segment remained relatively flat (+0.2%).
- Margin Expansion: Gross profit margin improved from 21.5% to 24.7%. This was primarily due to higher per-unit profits and increased sales of specialty products, despite a $0.8 million negative impact from LIFO inventory valuation adjustments.
- Cash Flow Decline: Operating cash flow decreased significantly to $4.6 million from $11.7 million. Management attributed this to increased working capital balances, specifically higher inventory purchases and trade receivables due to timing differences.
- Segment Performance: The Industrial segment contributed $1.9 million of the $2.3 million increase in operating income, while the Water Treatment segment contributed $0.4 million.
Outlook, Risks, and Management Commentary
- Raw Material Costs: Management anticipates increases in commodity costs for fiscal 2011 compared to fiscal 2010. This has already resulted in a $0.8 million increase in the LIFO reserve, reducing reported gross profit.
- Pricing Pressure: Stabilizing raw material costs and slower economic growth are expected to heighten competitive pricing pressure, potentially negatively affecting margins in the remainder of fiscal 2011.
- Capital Expenditures: Capital spending was $3.3 million for the quarter, focused on business expansion, process improvements, and safety upgrades. Management expects operating cash flows to be sufficient to fund planned expenditures.
- Market Risks: The company is exposed to interest rate risk regarding its fixed income investment portfolio ($32.5 million in CDs) and cyclical commodity chemical price fluctuations. The company does not currently hedge commodity purchases.
- Discontinued Operations: The Pharmaceutical segment was sold in May 2009; results are reported as discontinued operations. A receivable of approximately $1.7 million remains related to this transaction.
Investor Verification Checklist
- LIFO Impact: Verify the sensitivity of gross margins to future raw material cost increases, as the LIFO reserve adjustment negatively impacted Q1 results by $0.8 million.
- Working Capital Trends: Monitor the trajectory of inventory and receivables balances, as the timing of bulk chemical purchases significantly impacts operating cash flow volatility.
- Specialty Product Mix: Confirm the continued growth trajectory of higher-margin blended and manufactured products, which drove the margin expansion in the Water Treatment segment.
- Capital Allocation: Review the return on investment for new facilities in Centralia, Illinois, and Minneapolis, Minnesota, which are intended to support future growth.